Skip to main content
. 2020 Dec 23;13(1):21. doi: 10.3390/nu13010021

Table 2.

Comparison of fatty acid acylcarnitines between responders and non-responders. Acylcarnitines profile of responders (n = 12) and non-responders (n = 10). Group differences were analyzed by conducting generalized estimating equation (GEE) after adjusting confounding effect of anticonvulsants. R: responders; NR: non-responders.

Time (Month) β SE p Time (Month) β SE p
BHB 0 0.37 0.87 0.673 C6-DC carnitine 0 0.01 0.01 0.102
3 0.31 0.57 0.588 3 0.00 0.00 0.324
6 1.43 0.64 0.025 * 6 −0.01 0.01 0.031 *
9 −0.65 0.74 0.384 9 −0.01 0.00 0.275
12 −0.06 0.77 0.934 12 0.00 0.00 0.465
Free carnitine 0 −7.85 3.73 0.035 * C8 carnitine 0 −0.01 0.03 0.657
3 −11.84 4.05 0.003 *** 3 −0.07 0.07 0.333
6 −15.94 4.18 0.000 **** 6 0.01 0.01 0.405
9 −6.77 3.58 0.059 9 −0.06 0.01 0.000 ****
12 −8.59 3.11 0.006 ** 12 −0.01 0.01 0.230
C2 carnitine 0 −8.95 3.29 0.006 ** C10 carnitine 0 −0.02 0.04 0.688
3 −9.67 3.84 0.012 * 3 −0.06 0.05 0.240
6 −2.65 4.50 0.556 6 0.02 0.02 0.333
9 −1.60 4.96 0.747 9 −0.07 0.02 0.000 ****
12 1.464 5.3079 0.783 12 −0.03 0.02 0.112
C3 carnitine 0 −1.28 0.60 0.032 * C10:1 carnitine 0 0.01 0.03 0.664
3 −1.68 0.34 0.000 **** 3 0.02 0.02 0.355
6 −1.80 0.30 0.000 **** 6 0.02 0.02 0.144
9 −1.12 0.51 0.027 * 9 −0.08 0.01 0.000 ****
12 −0.98 0.43 0.022 * 12 −0.02 0.02 0.253
C4 carnitine 0 −0.05 0.06 0.456 C8/C10 carnitine 0 −0.04 0.17 0.817
3 −0.21 0.06 0.000 **** 3 0.07 0.15 0.628
6 −0.14 0.06 0.028 * 6 −0.02 0.11 0.846
9 −0.10 0.06 0.084 9 0.07 0.13 0.575
12 −0.03 0.05 0.547 12 −0.01 0.12 0.949
C4:OH carnitine 0 −0.07 0.03 0.033 * C12 carnitine 0 −0.02 0.02 0.337
3 −0.04 0.08 0.617 3 −0.07 0.03 0.027 *
6 0.06 0.07 0.404 6 −0.02 0.01 0.151
9 −0.07 0.08 0.379 9 −0.03 0.02 0.055
12 0.09 0.11 0.409 12 −0.01 0.02 0.560
C4-DC carnitine 0 −0.15 0.09 0.108 C14 carnitine 0 −0.04 0.02 0.022 *
3 −0.16 0.08 0.043 * 3 −0.11 0.08 0.146
6 −0.06 0.10 0.500 6 −0.04 0.01 0.007 **
9 0.05 0.08 0.550 9 −0.04 0.02 0.016 *
12 0.04 0.11 0.712 12 0.00 0.01 0.979
C5 carnitine 0 −0.02 0.04 0.592 C14:1 carnitine 0 −0.04 0.01 0.000 ****
3 −0.09 0.02 0.000 **** 3 −0.05 0.02 0.022 *
6 −0.10 0.01 0.000 **** 6 0.00 0.02 0.911
9 −0.07 0.02 0.002 *** 9 −0.05 0.02 0.009 **
12 −0.04 0.01 0.002 *** 12 −0.01 0.02 0.564
C5:1 carnitine 0 0.00 0.00 0.275 C14:2 carnitine 0 0.00 0.01 0.896
3 −0.01 0.00 0.013 * 3 −0.01 0.01 0.153
6 0.00 0.00 0.401 6 0.00 0.01 0.831
9 −0.01 0.00 0.001 *** 9 −0.03 0.01 0.003 ***
12 0.00 0.00 0.504 12 0.00 0.01 0.761
C5:OH carnitine 0 −0.08 0.09 0.371 C16 carnitine 0 −0.70 0.25 0.005 **
3 −0.12 0.04 0.006 ** 3 −1.08 0.35 0.002 ***
6 −0.10 0.05 0.062 6 −0.83 0.23 0.000 ****
9 −0.11 0.04 0.012 * 9 −0.62 0.21 0.003 ***
12 −0.11 0.09 0.224 12 −0.39 0.16 0.013 *
C5-DC carnitine 0 0.01 0.01 0.055 C16:1 carnitine 0 −0.07 0.03 0.011 *
3 −0.01 0.00 0.003 *** 3 −0.07 0.01 0.000 ****
6 0.00 0.00 0.232 6 −0.05 0.02 0.014 *
9 −0.02 0.01 0.011 * 9 −0.05 0.03 0.059
12 −0.01 0.00 0.005 *** 12 −0.01 0.01 0.235
C6 carnitine 0 −0.01 0.02 0.620 C18 carnitine 0 −0.47 0.08 0.000 ****
3 −0.09 0.06 0.152 3 −0.50 0.30 0.093
6 −0.02 0.00 0.000 **** 6 −0.51 0.18 0.004 ***
9 −0.02 0.01 0.031 * 9 −0.29 0.11 0.006 **
12 0.00 0.01 0.836 12 −0.22 0.16 0.168

β: regression weight; SE: Standard error; * p < 0.05, ** p < 0.01, *** p < 0.05, **** p < 0.001.